Skip to main content

Health-related quality of life and social determinants of health following COVID-19 infection in a predominantly Latino population



As the COVID-19 pandemic evolves, more information is needed on its long-term impacts on health-related quality of life (HRQoL) and social determinants of health (SDoH). The aim of the study was to assess HRQoL and SDoH among a predominantly Latino population of COVID-19 survivors and to compare effects in Latinos versus non-Latinos.


This cross-sectional study consisted of a survey (in English and Spanish) of COVID-19 survivors from December 2020 to July 2021. The study assessed sociodemographic data, clinical characteristics, and SDoH, consisting of 10 COVID-19—related concerns. The PROMIS-29 + 2 (PROPr) measure, which captures 8 HRQoL domains and a preference-based health utility, was used to assess HRQoL. Bivariate analyses included chi-square tests and t-tests. Generalized linear models were conducted for multivariable analyses.


Of 230 respondents (6.3% response rate), the mean [SD] age was 43.1 [14.3] years; 83.0% were Latino; the mean [SD] time since diagnosis was 8.1 [3.2] months; and 12.6% had a history of hospitalization with COVID-19. HRQoL scores were slightly worse than population norms on all domains, especially anxiety; the mean [SD] PROPr health utility was 0.36 [0.25]. Domain scores were similar by ethnicity except for cognitive function—abilities, where scores were lower in Latinos. Multivariable analyses revealed that: (1) financial concerns were associated with worse health utility, as well as worse scores on all 8 PROMIS domains; (2) interpersonal conflict was associated with worse health utility and worse scores on 6 of the 8 PROMIS domains (anxiety, depression, fatigue, sleep disturbance, social function, and pain interference); and (3) Latino ethnicity was only associated with 1 PROMIS domain (cognitive function—abilities) after controlling for covariates.


COVID-19 infection is associated with HRQoL decrements long after the acute infection, and financial concerns and interpersonal conflict are particularly associated with worse HRQoL.


The COVID-19 pandemic has claimed more lives in the U.S. than any previous pandemic and has caused substantial morbidity [1, 2]. In addition to the concerns associated with acute COVID-19 infection, research is emerging on the long-term impacts on the physical, mental, and social well-being of survivors 3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22]. While previous research indicates that COVID-19 survivors experience lingering symptoms adversely affecting physical and mental health, cognitive function, energy/fatigue, and sleep, thus far, most of the research has been conducted on small, homogenous samples with short follow-up periods, generally 6 or fewer months between diagnosis and assessment [11, 19, 11,19,23,24,25]. In addition, only a limited number of studies have examined multiple domains of health-related quality of life (HRQoL) in COVID-19 survivors. [14, 20, 21, 14,20,21,25,26,27]

Notably, the pandemic has also underscored racial and ethnic disparities, as minority populations have been disproportionately impacted [28]. Specifically, Latinos have suffered higher rates of COVID-19 infection, hospitalization, and death as compared with non-Latino whites [29, 30]. As of February 2022, Latinos were 1.5 times as likely to have contracted COVID-19, 2.4 times as likely to be hospitalized, and 1.9 times as likely to die from the disease as non-Latino whites [29]. While disparities in infection and mortality rates among Latinos are well-documented, to date, very little research has examined racial and ethnic differences in the recovery experience of COVID-19 survivors. [26]

The purpose of this study was to investigate the long-term impact of COVID-19 on HRQoL and social determinants of health (SDoH) among a majority Latino population of COVID-19 survivors in Texas, and to compare effects in Latinos versus non-Latinos. We assessed the PROPr health utility score, a preference-based measure of overall health utility constructed from the PROMIS-29 + 2 HRQoL measure. [31]


Study design and participants

This cross-sectional study consisted of a survey of COVID-19 survivors from metropolitan San Antonio, Texas enrolled in the COVID-19 Infectious Diseases Outpatient Clinic (CIVOC) cohort registry, created in March 2020. All individuals in the registry were diagnosed with COVID-19 by a positive PCR test either as an inpatient or outpatient. Study participants were recruited from the CIVOC registry via postal mail; the mailing included a link to the REDCap survey and instructions for obtaining a paper copy of the survey. Multiple modes of survey administration (electronic and paper) were used to increase the response rate; previous research suggests that mode of survey administration does not impact the reliability or validity of PROMIS scales [32]. Inclusion criteria included (1) a history of COVID-19 infection diagnosed from March 13, 2020–November 21, 2020; (2) age 18 years or older with validated age, sex, and ethnicity data; (3) reading and writing fluency in English or Spanish; (4) residence in Bexar County, Texas; and (5) complete and deliverable mail address information. Data were collected from December 2020 to July 2021; participants participated in the survey (English or Spanish) online through REDCap or returned a paper survey. Two mailings were used to recruit participants for the study; the first occurred in December 2020, the second mailing was sent in April 2021 to those who did not respond to the first study invitation. Consent was obtained electronically via REDCap or on paper if participants chose to return the survey by mail. Participants were compensated $20 following completion of the survey. This study was approved by the University of Texas Health Science Center at San Antonio Institutional Review Board (HSC-2020-0765E).

Data sources and variables

HRQoL and SDoH

To assess HRQoL, we used the 31-item PROMIS-29 + 2 (PROPr) measure, which addresses 8 health domains: anxiety, depression, fatigue, pain interference, physical function, sleep disturbance, ability to participate in social roles and activities, and cognitive function—abilities. Cognitive function—abilities assesses items related to cognitive functioning including memory and concentration [33]. The PROMIS measures have demonstrated reliability and construct validity in diverse populations [34]. PROMIS scoring includes calculation of a T-score, which is used to compare sample scores versus the general population (mean = 50, SD = 10). Higher T-scores correspond to higher levels of the construct (for example, greater anxiety, better physical function). In addition, the measure produces a PROPr score, an overall health utility ranging from -0.022 (worst) to 1.0 (best). [35]

To assess SDoH, we developed a set of items addressing COVID-19 concerns and needs. The question stem was, “Based on your experience with COVID-19, which of the following are you most worried about over the next several months? (Please select ALL that apply),” and the response options were: (1) ongoing COVID-related health impacts; (2) being able to access COVID-related healthcare, including vaccines or treatments; (3) having enough money to cover essential expenses (food, housing, bills, etc.); (4) getting or keeping a job; (5) education/schooling for self or others; (6) childcare; (7) caring for sick/aged family members; (8) having a stable place to live; (9) conflict within the home or with family members; and (10) other. Variables were created for each of the potential response options; coding corresponded for 1 “selected” and 0 “not selected”.

Demographics and clinical variables

We obtained clinical data for the date of COVID-19 diagnosis and hospitalization records from the CIVOC registry. We defined history of hospitalization as either hospitalization for COVID-19 infection, or a COVID-19 diagnosis made during hospitalization for another primary diagnosis. For demographic characteristics, the CIVOC student research team verified race, ethnicity, and date of birth for all patients in the COVID-19 cohort by searching for their medical record number (MRN) in the Electronic Health Record to confirm the integrity of the data transfer into the CIVOC registry. Data on respondents’ age, sex, ethnicity (Latino/ non-Latino) were also cross validated between the survey and registry.

Statistical analysis

The analytic dataset consisted of respondents with complete PROMIS-29 + 2 data. Eighty-four participants with incomplete PROMIS-29 + 2 data were removed from the analyses and 2 additional participants with missing covariates were also excluded from the analyses. In addition to calculating descriptive statistics, we conducted bivariate and multivariable analyses. Bivariate analyses included chi-square tests for categorical variables and t-tests for continuous measures. The effect size of ethnicity on each HRQoL and COVID-19 concern variable was calculated as the difference of means between ethnic groups divided by the pooled standard deviation (Cohen’s d formula). Multivariable analyses consisted of 9 multivariable regression models, in which the outcome variables were the PROPr health utility score and the 8 PROMIS domains. Exposure variables in the multivariable analyses included Latino ethnicity, age, sex, prior hospitalization for COVID-19, months since diagnosis, and SDoH. The stepwise forward selection and backward elimination method was used to select variables in the final models, where p < 0.15 was used as the entry significance level and p < 0.05 as the retention significance level. Because Latino ethnicity was an exposure of interest, it was included in the final models regardless of statistical significance.


The total number of respondents to the survey was 359, of whom we excluded 129, for a final sample of 230 (Fig. 1). The response rate was 6.3%; corresponding to those who completed all variables of interests (n = 230), divided by those eligible to complete the study (n = 3659). Compared with eligible participants in the CIVOC registry who did not complete our survey, our sample was slightly over-represented by women and participants with outpatient (vs. inpatient) COVID-19 diagnoses (Table 1). Overall, the mean [SD] age 43.1 [14.3] years, 83.0% of COVID-19 survivors were Latino, 68.7% were female, and 12.6% had been hospitalized. The mean [SD] number of months since diagnosis was 8.1 [3.2] (Table 2). Demographic results were similar for Latinos vs. non-Latinos except that the time elapsed since COVID-19 diagnosis was greater for Latinos.

Fig. 1
figure 1

Study flow diagram

Table 1 Demographics of the included sample versus non-responders
Table 2 Comparison of demographic and clinical characteristics by ethnicity

HRQoL scores were slightly worse than population norms for 7 of the 8 PROMIS domains, and the mean [SD] PROPr health utility was 0.36 [0.25] (Table 3). In bivariate analyses comparing HRQoL scores by ethnicity, cognitive function—abilities scores were lower among Latinos than non-Latinos. In addition to being statistically significant, the differences between cognitive function—abilities scores also met the threshold for minimal clinically important difference of 3 T-scores points [36]; the effect size for the difference was small. PROPr health utility scores did not differ for Latinos as compared with non-Latinos. Among SDoH, the most prevalent were health-related impacts (67.4%), as well as financial (45.2%), and employment (31.7%) concerns. Significantly greater proportions of Latinos as compared with non-Latinos reported concerns regarding access to healthcare (24.6% vs. 10.3%; p = 0.05) and finances (49.2% vs. 25.6%; p = 0.007). Among the SDoH variables that were statistically different between Latinos and non-Latinos, financial concerns had the largest effect size (0.36), followed by access to health care (0.27); both effect sizes were small.

Table 3 Health-related quality of life and COVID-19 concerns

In multivariable regression analyses of HRQoL outcomes, the SDoH most associated with HRQoL scores were financial concerns and interpersonal conflict (Table 4). Financial concerns were significantly associated with worse health utility and all 8 of the PROMIS domains. Interpersonal concerns were associated with worse health utility and social function; greater anxiety, depression, fatigue, pain interference, and sleep disturbance. In addition to financial and interpersonal concerns, health-related impacts of COVID-19 were also significantly associated with greater anxiety; concern over education for themselves or others was associated with reduced pain interference. For demographic and clinical covariates, the results differed across models. Older age was significantly associated with worse physical function, pain interference, and social function. Longer time since diagnosis and Latino ethnicity were significantly associated with worse cognitive function—abilities.

Table 4 Multivariable regression analyses examining the associations between demographics, clinical characteristics, COVID-19 concerns and health-related quality of life domains


In this relatively large, predominantly Latino, cross-sectional study of COVID-19 survivors, we assessed SDoH and HRQoL on average 8 months post-diagnosis. Notable findings include slightly worse HRQoL scores relative to population norms in 7 of the 8 PROMIS domains, as well as reduced health utility.

To date, there has been limited research examining HRQoL among COVID-19 survivors beyond a short time after diagnosis and among ethnically diverse samples. In 1 of the largest studies of COVID-19 survivors (n = 819), Ganesh and colleagues assessed the impact of COVID-19 infection on HRQoL of COVID-19 survivors drawn from the Mayo Clinic [21]. Overall, respondents reported significantly worse scores (greater than 1 SD) as compared with the expected population mean with respect to social roles, pain, fatigue, physical function, and sleep. Their follow-up time between COVID-19 diagnosis and survey completion was only 68 days, however. In addition, the sample was primarily non-Latino white (86%) and additional HRQoL constructs such as depression, anxiety, and cognitive function were not assessed. In a study with a longer follow-up between diagnosis and survey administration (approximately 6 months), researchers found that, among COVID-19 survivors (n = 177), nearly a third reported at least 1 persistent physical symptom [22]. In a recent study of survivors of severe COVID-19 (i.e. requiring intensive care unit admission), researchers found at 6 months follow up that respondents (n = 132) did not differ from the U.S. population on PROMIS 29-2 domain scores, with the exception of physical function (mean [SD] 44.2 [11.0]) and global mental health scores (mean [SD] 43.1 [10.8]) [27]. Importantly, that study did not examine differences between Latinos and non-Latinos and did not examine the relationships between SDoH and HRQoL outcomes.

In our study, the HRQoL domain that was most abnormal relative to population norms was anxiety. In multivariable analysis, 3 SDoH factors were associated with greater anxiety: health-related impacts, financial concerns, and interpersonal conflict within the home or with other family members. These results are consistent with a systematic review demonstrating that anxiety is 1 of the most common symptoms of PASC [24]. In that review, across 7 studies that reported symptoms of anxiety among COVID-19 survivors, 30% of subjects were diagnosed with generalized anxiety disorder. In a study that utilized PROMIS to assess anxiety among hospitalized patients with COVID-19 in Israel (n = 90), patients had moderately high levels of anxiety (mean [SD] T-score, 57.7 [11.9]). [5]

Furthermore, the consistent associations between 2 SDoH, financial concerns and interpersonal conflict, with health utility and the PROMIS domains demonstrate the salience of these SDoH as it relates to HRQoL. Recent research by Hanmer has also shown that SDoH are associated with health utility. Specifically, Hanmer found that health utility scores were associated with education, income, employment, difficulty getting to medical appointments, food and financial insecurity, intimate partner violence, stress, and social situation [31]. Importantly. economic impacts may be particularly salient for our study’s majority Latino population, since Latino workers suffer higher unemployment rates than non-Latino whites [37]. In one of the only studies that has investigated the impacts of COVID-19 on mental health outcomes among Latinos, researchers found that economic strain (e.g. job loss, inability to afford rent) due to COVID-19 was associated with increased anxiety symptoms, while psychosocial consequences (e.g. loss of important relationships, substance use) were associated with both increased anxiety and depressive symptoms among a sample of young adults [38]. Our findings differ from that study in that financial concerns were associated with both increased anxiety and depression. Notably, the study by Villatoro and colleagues included Latino young adults and was not specific to COVID-19 survivors. Financial concerns may be more prominent for COVID-19 survivors as many have to take significant amounts of time off work while they recover from the illness [39]. While previous research has demonstrated associations between SDoH, such as COVID-19-related financial concerns, with negative mental health outcomes [38, 40, 41]; no studies have examined their impact on physical health PROMIS domains, such as physical function, pain interference, and fatigue.

Finally, specific to cognitive function—abilities, financial concerns, along with Latino ethnicity and time since diagnosis, were associated with worse scores. In other words, the longer since diagnosis, the worse the cognitive function. Here, our study is limited by the cross-sectional design, so we do not know whether cognitive function changed over time. The lower cognitive function—abilities scores among Latinos could be explained by variables that we did not measure. Many previous studies have demonstrated that diminished cognitive function, or “brain fog,” is common in PASC [24, 26, 33]. In an analysis of factors contributing to diminished cognitive function due to COVID-19 infection, Baker and co-authors attributed: (1) pre-existing conditions such as advanced age, diabetes, or obesity; (2) COVID-19 inflammation leading to hypoxia, ischemia, and neuronal injury; and (3) treatment effects such as prolonged sedation [42]. While we did not collect information on comorbidities, research suggests that Latinos may suffer more adverse outcomes from COVID-19 due to greater rates of pre-existing conditions, such as hypertension, diabetes, and obesity [43, 44]. In South Texas, diabetes and obesity are more common among Latinos than non-Latinos [45]. These same underlying conditions may also negatively impact cognitive function among COVID-19 survivors. Moreover, our findings regarding cognitive function should be interpreted with the consideration that although the survey was administered in both English and Spanish, we did not assess additional acculturation measures including primary language spoken at home, which may impact scores on the cognitive function—abilities measure. As a result, reduced cognitive function may be confounded by unmeasured factors as opposed to reflecting true differences in function.

Our study provides important insight into HRQoL within a predominantly Latino population on average 8 months following COVID-19 diagnosis. As noted previously, most research on COVID-19 survivors has included mostly non-Latino white samples, with 6 months or less time from diagnosis to follow-up [24]. In a systematic review by Groff and colleagues of 57 articles examining short and long-term consequences of COVID-19, only 13 had larger sample sizes than our study [24]. Of those 13 studies, only 3 were conducted in the U.S. [4, 12, 46] and only 1 had a follow-up of 6 months or longer [47]. Similarly, the more recent study by Neville and co-authors had a smaller sample size (n = 132) than our study, and surveyed participants at 6 months post-hospital discharge. [27]

While the current study has numerous strengths, a few limitations warrant discussion. First, the study was cross-sectional; therefore, we do not have HRQoL or SDoH data prior to COVID-19 infection, and as such, we do not know if COVID-19 is the direct cause of the reduced HRQoL among survivors. As stated previously, we did not assess acculturation measures, such as language spoken at home, or information regarding comorbidities, which might bias the results in favor of finding a stronger association between Latino ethnicity and reduced cognitive function. Additionally, COVID-19 survivors who participated in our study differed in certain respects from those in the COVID-19 registry as a whole; our sample had greater proportions of women and outpatient COVID-19 diagnoses than non-responders. Therefore, our results are not generalizable to the full COVID-19 registry. Importantly, however, because a larger proportion of non-responders were hospitalized when they were diagnosed with COVID-19, their patient-reported outcomes may be worse than those observed in our sample. Furthermore, the small number of non-Latino participants (n = 39) might have prevented the detection of important significant differences between Latinos and non-Latinos on SDoH and HRQoL variables. An additional limitation is that the measure used to assess SDoH asked which concerns from a list the patient is most worried about, and then instructed participants to select all that apply. Given this wording, some participants may have only selected one concern (the most concerning one), thus partly obscuring the relationships we found between SDoH and HRQoL outcomes.

Another limitation of the study is the low response rate; there are several reasons that may explain this phenomenon. First, our sample was recruited from a registry that was created for clinical care, as opposed to for research. Low response rate to the survey may also be attributed to reluctance to engage in COVID-19 research due to social, political, or religious factors. Finally, an additional limitation is the lack of information regarding patients’ past medical histories, pre-existing conditions, reasons for hospitalization, and the severity of COVID-19 infection. Notably, the registry was created as a tool to allow providers to identify patients who have had COVID-19 infection and arrange appropriate follow up.

In spite of these limitations, our study has many strengths, including assessment of HRQoL at an average of 8 months post-infection, which provides needed insight into the long-term recovery from COVID-19. Furthermore, unlike previous research, our study population is majority minority, with 83.0% of participants identifying as Latino. Our participants were also not limited to those with severe COVID-19 infection requiring hospitalization, as only 12.6% of our sample were diagnosed while hospitalized with COVID-19.


This study is one of the first to investigate the long-term impact of COVID-19 infection and SDoH among a majority minority patient population. Our results demonstrate that COVID-19 infection can be associated with HRQoL decrements long after the acute infection, and various demographic factors and SDoH are associated with worse HRQoL. Future studies should follow patients longitudinally well beyond the time of infection and should test both medical and social interventions to mitigate HRQoL loss.

Availability of data and materials

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.


  1. Johns Hopkins University and Medicine. COVID-19 map. Coronavirus Resource Center. Accessed 27 Oct 2021

  2. Murez C (2021) COVID has killed more Americans than the Spanish Flu did in 1918. US News & World Report. Accessed 27 Oct 2021

  3. Huang L, Yao Q, Gu X et al (2021) 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet 398(10302):747–758.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  4. Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ (2021) 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Dorman-Ilan S, Hertz-Palmor N, Brand-Gothelf A et al (2020) Anxiety and depression symptoms in COVID-19 isolated patients and in their relatives. Front Psychiatry 11:581598.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Sudre CH, Murray B, Varsavsky T et al (2021) Attributes and predictors of long COVID. Nat Med 27(4):626–631.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  7. Menges D, Ballouz T, Anagnostopoulos A et al (2021) Burden of post-COVID-19 syndrome and implications for healthcare service planning: a population-based cohort study. PLoS ONE 16(7):e0254523.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  8. Nehme M, Braillard O, Alcoba G et al (2021) COVID-19 symptoms: longitudinal evolution and persistence in outpatient settings. Ann Intern Med.

    Article  PubMed  PubMed Central  Google Scholar 

  9. The Writing Committee for the COMEBAC Study Group (2021) Four-month clinical status of a cohort of patients after hospitalization for COVID-19. JAMA.

    Article  PubMed Central  Google Scholar 

  10. Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ (2021) Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLOS Med 18(9):e1003773.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  11. Lopez-Leon S, Wegman-Ostrosky T, Perelman C et al (2021) More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep 11(1):16144.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  12. Chopra V, Flanders SA, O’Malley M, Malani AN, Prescott HC (2021) Sixty-day outcomes among patients hospitalized with COVID-19. Ann Intern Med.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Arnold DT, Hamilton FW, Milne A et al (2021) Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax 76(4):399–401.

    Article  PubMed  Google Scholar 

  14. Qin ES, Gold LS, Hough CL et al (2021) Patient-reported functional outcomes thirty days after hospitalization for COVID-19. PM&R J Injury Funct Rehabil.

    Article  Google Scholar 

  15. Townsend L, Dowds J, O’Brien K et al (2021) Persistent poor health post-COVID-19 Is not associated with respiratory complications or initial disease severity. Ann Am Thorac Soc. Published online January 8, 2021.

  16. Carfì A, Bernabei R, Landi F et al (2020) Persistent symptoms in patients after acute COVID-19. JAMA 324(6):603.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  17. Yomogida K (2021) Post-Acute sequelae of SARS-CoV-2 infection among adults aged ≥ 18 years—Long Beach, California, April 1–December 10, 2020. Morb Mortal Wkly Rep 70.

  18. Augustin M, Schommers P, Stecher M et al (2021) Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur 6:100122.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Salamanna F, Veronesi F, Martini L, Landini MP, Fini M (2021) Post-COVID-19 syndrome: the persistent symptoms at the post-viral stage of the disease. A systematic review of the current data. Front Med 8:653516.

    Article  Google Scholar 

  20. Weerahandi H, Hochman KA, Simon E et al (2020) Post-discharge health status and symptoms in patients with severe COVID-19. medRxiv. Published online August 14, 2020.08.11.20172742.

  21. Ganesh R, Ghosh AK, Nyman MA et al (2021) PROMIS scales for assessment of persistent post-COVID symptoms: a cross sectional study. J Prim Care Community Health 12:21501327211030412.

    Article  Google Scholar 

  22. Logue JK, Franko NM, McCulloch DJ et al (2021) Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw Open 4(2):e210830.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Dorri M, Mozafari Bazargany MH, Khodaparast Z et al (2021) Psychological problems and reduced health-related quality of life in the COVID-19 survivors. J Affect Disord Rep 6:100248.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Groff D, Sun A, Ssentongo AE et al (2021) Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw Open 4(10):e2128568.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Horwitz LI, Garry K, Prete AM et al (2021) Six-month outcomes in patients hospitalized with severe COVID-19. J Gen Intern Med. Published online August 5, 2021.

  26. Frontera JA, Lewis A, Melmed K et al (2021) Prevalence and predictors of prolonged cognitive and psychological symptoms following COVID-19 in the United States. Front Aging Neurosci 13:690383.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  27. Neville TH, Hays RD, Tseng CH et al (2022) Survival After severe COVID-19: long-term outcomes of patients admitted to an Intensive Care Unit. J Intensive Care Med. Published online 2022:08850666221092687

  28. Gruber J, Clark LA, Abramowitz JS et al (2021) Mental health and clinical psychological science in the time of COVID-19: challenges, opportunities, and a call to action. Am Psychol 76(3):409–426.

    Article  PubMed  Google Scholar 

  29. COVID-19 hospitalization and death by race/ethnicity. Centers for Disease Control and Prevention. Last Updated February 1, 2022. Accessed 7 Feb 2022

  30. Macias Gil R, Marcelin JR, Zuniga-Blanco B, Marquez C, Mathew T, Piggott DA (2020) COVID-19 pandemic: disparate health impact on the Hispanic/Latinx population in the United States. J Infect Dis 222(10):1592–1595.

    CAS  Article  PubMed  Google Scholar 

  31. Hanmer J (2021) Cross-sectional validation of the PROMIS-preference scoring system by its association with social determinants of health. Qual Life Res 30(3):881–889.

    Article  PubMed  Google Scholar 

  32. Bjorner JB, Rose M, Gandek B et al (2014) Method of administration of PROMIS scales did not significantly impact score level, reliability, or validity. J Clin Epidemiol 67(1):108–113.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Becker JH, Lin JJ, Doernberg M et al (2021) Assessment of cognitive function in patients after COVID-19 infection. JAMA Netw Open 4(10):e2130645.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Cella D, Choi SW, Condon DM et al (2019) PROMIS® adult health profiles: efficient short-form measures of seven health domains. Value Health 22(5):537–544.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Dewitt B, Feeny D, Fischhoff B et al (2018) Estimation of a preference-based summary score for the Patient-Reported Outcomes Measurement Information System: the PROMIS®-preference (PROPr) scoring system. Med Decis Mak 38(6):683–698.

    Article  Google Scholar 

  36. Meaningful change for PROMIS®. Health Measures. Accessed 11 May 2022

  37. Gould E, Perez D, Wilson V (2020) Latinx workers—particularly women—face devastating job losses in the COVID-19 recession. Economic Policy Institute. Accessed 22 Oct 2021

  38. Villatoro AP, Wagner KM, de Snyder S et al (2021) Economic and social consequences of COVID-19 and mental health burden among Latinx young adults during the 2020 pandemic. J Latinx Psychol 10(1):25.

    Article  Google Scholar 

  39. Frontera JA, Yang D, Lewis A et al (2021) A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications. J Neurol Sci 426:117486.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  40. Zheng J, Morstead T, Sin N et al (2021) Psychological distress in North America during COVID-19: the role of pandemic-related stressors. Soc Sci Med 270:113687.

    Article  PubMed  Google Scholar 

  41. Jones HE, Manze M, Ngo V, Lamberson P, Freudenberg N (2021) The impact of the COVID-19 pandemic on college students’ health and financial stability in New York City: findings from a population-based sample of City University of New York (CUNY) students. J Urban Health 98:187–196.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Baker HA, Safavynia SA, Evered LA (2021) The ‘third wave’: impending cognitive and functional decline in COVID-19 survivors. Br J Anaesth 126(1):44–47.

    CAS  Article  PubMed  Google Scholar 

  43. Garg S (2020) Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019—COVID-NET, 14 States, March 1–30, 2020. Morb Mortal Wkly Rep 69.

  44. Garcia MA, Homan PA, García C, Brown TH (2021) The color of COVID-19: structural racism and the disproportionate impact of the pandemic on older black and Latinx adults. J Gerontol Ser B 76(3):e75–e80.

    Article  Google Scholar 

  45. Ramirez AG, Thompson IM, Vela L (eds) (2013) The South Texas Health Status Review: A Health Disparities Roadmap. Springer International Publishing.

    Book  Google Scholar 

  46. Huang Y, Pinto MD, Borelli JL et al (2021) COVID symptoms, symptom clusters, and predictors for becoming a long-hauler: looking for clarity in the haze of the pandemic. medRxiv. Published online 2021. Accessed 27 Oct 2021

  47. Huang C, Huang L, Wang Y et al (2021) 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet.

    Article  PubMed  PubMed Central  Google Scholar 

Download references


The authors thank Dr. Janel Hanmer, MD, PHD, Associate Professor of Medicine at the Department of General Internal Medicine, University of Pittsburgh Medical Center, for her expertise and guidance interpreting our findings.


The research was supported by Grants from the Bexar County Health Collaborative and the Institute for Integration of Medicine and Science at the University of Texas Health Science Center at San Antonio. The funding sources played no role in the design, conduct, or analysis of the study or the decision to submit the manuscript for publication.

Author information

Authors and Affiliations



All authors participated in the research and/or article preparation process. KC: funding acquisition, conceptualization, and writing-original draft. CPW: formal analysis, validation, writing-review and editing. MH: data curation, project administration, writing-review and editing. SL: writing-review and editing, resources. AH: conceptualization, writing-review, and editing. BT: data curation, project administration, writing-review and editing. JB: data curation. DM: data curation, formal analysis, validation. PW: conceptualization, writing-review. JT: funding acquisition, conceptualization, writing-review and editing.

Corresponding author

Correspondence to Kathleen R. Case.

Ethics declarations

Ethics approval and consent to participate

The study was approved by the University of Texas Health Science Center at San Antonio’s Institutional Review Board (protocol number: 20200765EX).

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Case, K.R., Wang, CP., Hosek, M.G. et al. Health-related quality of life and social determinants of health following COVID-19 infection in a predominantly Latino population. J Patient Rep Outcomes 6, 72 (2022).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI:


  • COVID-19
  • Quality of life
  • Latinos
  • PROMIS-29 + 2
  • Patient-reported outcomes
  • Social determinants of health
  • Long COVID
  • Post-acute sequelae of COVID-19
  • Health disparities